Copyright
©The Author(s) 2024.
World J Exp Med. Sep 20, 2024; 14(3): 95540
Published online Sep 20, 2024. doi: 10.5493/wjem.v14.i3.95540
Published online Sep 20, 2024. doi: 10.5493/wjem.v14.i3.95540
Table 1 Clinical characteristics of the study population
Characteristics | Number |
Age in yr | 64.5 (53-72) |
Sex | |
Male | 249 (59.6) |
Female | 169 (40.4) |
Risk factor | |
Hypertension | 299 (71.5) |
Dyslipidemia | 276 (66) |
Diabetes mellitus | 141 (33.7) |
Atrial fibrillation/atrial flutter | 102 (24.4) |
Old stroke | 47 (11.2) |
Current smoking | 73 (17.5) |
Current alcohol drinking | 42 (10) |
Etiology | |
Other determined or undetermined | 177 (42.3) |
Cardioembolic | 102 (24.4) |
Small-artery occlusion | 94 (22.5) |
Large-artery atherosclerosis | 42 (10) |
Medication before stroke onset | |
Antihypertensive therapy | 202 (48.3) |
Antiplatelet therapy | 81 (18.3) |
Hypoglycemic therapy | 121 (27.3) |
Time for stroke onset to intravenous rtPA infusion in min | 170.05 (124-218.25) |
Infarct volume in mL | 3.27 (0.58-24.24) |
Hemorrhagic transformation | |
No | 343 (82) |
Yes | 75 (82) |
PH1 | 29 (82) |
PH2 | 27 (6.1) |
HI1 | 12 (2.7) |
HI2 | 7 (1.6) |
- Citation: Chaiwisitkun A, Muengtaweepongsa S. Platelet-to-neutrophil ratio predicts hemorrhagic transformation and unfavorable outcomes in acute ischemic stroke with intravenous thrombolysis. World J Exp Med 2024; 14(3): 95540
- URL: https://www.wjgnet.com/2220-315x/full/v14/i3/95540.htm
- DOI: https://dx.doi.org/10.5493/wjem.v14.i3.95540